Cargando…

miRNA-135b Contributes to Triple Negative Breast Cancer Molecular Heterogeneity: Different Expression Profile in Basal-like Versus non-Basal-like Phenotypes

The clinical and genetic heterogeneity of Triple Negative Breast Cancer (TNBC) and the lack of unambiguous molecular targets contribute to the inadequacy of current therapeutic options for these variants. MicroRNAs (miRNA) are a class of small highly conserved regulatory endogenous non-coding RNA, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uva, Paolo, Cossu-Rocca, Paolo, Loi, Federica, Pira, Giovanna, Murgia, Luciano, Orrù, Sandra, Floris, Matteo, Muroni, Maria Rosaria, Sanges, Francesca, Carru, Ciriaco, Angius, Andrea, De Miglio, Maria Rosaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930454/ https://www.ncbi.nlm.nih.gov/pubmed/29725243 http://dx.doi.org/10.7150/ijms.23402

Ejemplares similares

Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype
por: Angius, Andrea, et al.
Publicado: (2020)

Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype
por: Angius, Andrea, et al.
Publicado: (2022)

Landscape of transcriptome variations uncovering known and novel driver events in colorectal carcinoma
por: Pira, Giovanna, et al.
Publicado: (2020)

Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome
por: Angius, Andrea, et al.
Publicado: (2021)

Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer
por: Cossu-Rocca, Paolo, et al.
Publicado: (2015)

A Portrait of Intratumoral Genomic and Transcriptomic Heterogeneity at Single-Cell Level in Colorectal Cancer
por: Angius, Andrea, et al.
Publicado: (2021)

Integrated Analysis of miRNA and mRNA Endorses a Twenty miRNAs Signature for Colorectal Carcinoma
por: Angius, Andrea, et al.
Publicado: (2019)

Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in breast cancer: a Sardinian preliminary case-control study
por: Castiglia, Paolo, et al.
Publicado: (2019)

HPV infection and triple-negative breast cancers: an Italian case-control study
por: Piana, Andrea Fausto, et al.
Publicado: (2014)

MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers
por: Angius, Andrea, et al.
Publicado: (2019)

Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes
por: Orrù, Sandra, et al.
Publicado: (2022)

Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review
por: Arru, Caterina, et al.
Publicado: (2021)

Prognostic Impact of Membranous/Nuclear Epidermal Growth Factor Receptor Localization in Clear Cell Renal Cell Carcinoma
por: Muroni, Maria Rosaria, et al.
Publicado: (2021)

MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia
por: Floris, Matteo, et al.
Publicado: (2020)

Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients
por: Urru, Silvana Anna Maria, et al.
Publicado: (2018)

Harnessing Minimal Residual Disease as a Predictor for Colorectal Cancer: Promising Horizons Amidst Challenges
por: Wen, Xiaofen, et al.
Publicado: (2023)

Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype
por: Orrù, Sandra, et al.
Publicado: (2023)

Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in TP53, MDM2 and ATM genes in Sardinian women
por: Floris, Matteo, et al.
Publicado: (2022)

Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis
por: Sanges, Francesca, et al.
Publicado: (2020)

Metaproteomic Profile of the Colonic Luminal Microbiota From Patients With Colon Cancer
por: Tanca, Alessandro, et al.
Publicado: (2022)

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
por: Dogra, Atika, et al.
Publicado: (2020)

Quantitative Metabolomics to Explore the Role of Plasma Polyamines in Colorectal Cancer
por: Coradduzza, Donatella, et al.
Publicado: (2022)

Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
por: Niwińska, Anna, et al.
Publicado: (2011)

Are triple-negative tumours and basal-like breast cancer synonymous?
por: Rakha, Emad A, et al.
Publicado: (2007)

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
por: Wiese, David A, et al.
Publicado: (2013)

The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
por: Temian, Daiana Cosmina, et al.
Publicado: (2018)

Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response
por: Kreike, Bas, et al.
Publicado: (2007)

p16 expression correlates with basal-like triple-negative breast carcinoma
por: Abou-Bakr, Amany A, et al.
Publicado: (2013)

Decoding the Microbiome’s Influence on Rheumatoid Arthritis
por: Coradduzza, Donatella, et al.
Publicado: (2023)

The Differences in Ultrasound and Clinicopathological Features between Basal-Like and Normal-Like Subtypes of Triple Negative Breast Cancer
por: Li, Ziyao, et al.
Publicado: (2015)

Mammography and ultrasound effective features in differentiating basal-like and normal-like subtypes of triple negative breast cancer
por: Zeng, Zeng, et al.
Publicado: (2017)

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
por: Kreike, Bas, et al.
Publicado: (2007)

A clinically relevant gene signature in triple negative and basal-like breast cancer
por: Rody, Achim, et al.
Publicado: (2011)

Calpain system protein expression in basal-like and triple-negative invasive breast cancer
por: Storr, S. J., et al.
Publicado: (2012)

Biomarkers for Basal-like Breast Cancer
por: Choo, Jennifer R., et al.
Publicado: (2010)

NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells
por: Miano, Carmen, et al.
Publicado: (2022)

The Met oncogene and basal-like breast cancer: another culprit to watch out for?
por: Gastaldi, Stefania, et al.
Publicado: (2010)

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
por: Elsheikh, S E, et al.
Publicado: (2008)

Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2010)

Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
por: Wu, Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_im4nvv2t9e63fdgrc8k06k7dfm